DKCM
MDCO

Davidson Kempner Capital Management’s Medicines Co MDCO Stock Holding History

Davidson Kempner Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-171,900
Closed -$6.52M – 194
2015
Q3 		$6.52M Sell
171,900
-7,300
-4% -$256K 0.12% 114
2015
Q2 		$5.13M Buy
+179,200
New +$4.99M 0.08% 124

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Davidson Kempner Capital Management's MDCO Position: Q4 2015 in Review

Davidson Kempner Capital Management sold out of Medicines Co (MDCO) in Q4 2015, closing a stake of 171,900 shares — an estimated $6.52M sold.

Davidson Kempner Capital Management first reported a position in MDCO in Q2 2015 and held it in 2 quarters. The position peaked at $6.52M in Q3 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q4 2015.

  • Davidson Kempner Capital Management reported no remaining Medicines Co position as of Q4 2015 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 171,900 Medicines Co shares in Q4 2015, an estimated $6.52M.
  • Davidson Kempner Capital Management first reported a position in Medicines Co in Q2 2015 and held it in 2 quarters.
  • Davidson Kempner Capital Management's Medicines Co position peaked at $6.52M in Q3 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q4 2015.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.